Tweetovi

Blokirali ste korisnika/cu @RocheSequencing

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RocheSequencing

  1. 16. lis 2019.

    Interested in learning about the opportunities and challenges in developing optimal exome workflows? Come to our “Better by Design” Colab today at 1:45pm in Theater 3.

    Poništi
  2. 15. lis 2019.

    Come to our “Better by Design” Laboratory Colab tomorrow on October 16 at 1:45pm in Theater 3.

    Poništi
  3. 15. lis 2019.

    Come and visit our booth 701 at to learn about our Next Generation Sequencing portfolio.

    Poništi
  4. 15. lis 2019.

    Don’t miss an exciting symposium together with at on and : synergistic strategies for your practice. 15 Oct, 2019, 13:00 – 14:00, Convention Hall D. Learn more

    Poništi
  5. 15. lis 2019.

    We are at in Berlin, Germany. Stop by Roche booth 9 and learn about solutions. Join our symposium and poster presentations. Learn more

    Poništi
  6. 30. ruj 2019.

    Visit Roche booth 303 to learn more about our NGS solutions for comprehensive genomic profiling, surveillance and monitoring

    Poništi
  7. 29. ruj 2019.

    Please join Roche for a poster presentation at "Enhanced Access to EGFR Molecular Testing in NSCLC using a Cell-Free DNA Tube for Liquid Biopsy" 30 Sept | 1416P

    Poništi
  8. 27. ruj 2019.

    can improve patient access to targeted therapies. Visit Roche booth 303 at to learn more.

    Poništi
  9. 27. ruj 2019.

    Come see Roche's poster presentation "An exploratory analysis of on-treatment ctDNA measurement as a potential surrogate for overall survival for atezolizumab benefit in the OAK Study" 28 Sept at 12:00 | 1559P

    Poništi
  10. 26. ruj 2019.

    Check out Roche's poster presentation "Mutational profiling of tumor tissue and sequential plasma illustrates emergent clones during treatment in late stage small cell lung cancer (SCLC)" 28 Sept at 12:00 | 1744P

    Poništi
  11. 26. ruj 2019.

    Visit Roche during our poster presentation "Disease monitoring of EGFR mutation-positive NSCLC patients via circulating tumor DNA" 28 Sept at 12:00 | 1560P

    Poništi
  12. 25. ruj 2019.

    Learn about the only companion diagnostic that's FDA-approved for non-small cell lung cancer (NSCLC) at Roche booth 303

    Poništi
  13. 24. ruj 2019.

    Come visit Roche Diagnostics at booth 303 to hear more about our solutions

    Poništi
  14. 9. ruj 2019.

    Visit Roche booth 400 at to learn more about the NAVIFY Mutation Profiler and see a . Learn more at

    Poništi
  15. 8. ruj 2019.

    Visit Roche during our poster presentation "Early Assessment of Therapy Response in Non-small Cell Lung Cancer (NSCLC) via Longitudinal ctDNA Analysis" Poster 2795 | 9 Sept

    Poništi
  16. 7. ruj 2019.

    Come see Roche's poster "Assessing the impact of clonal hematopoiesis in disease monitoring using targeted cell-free DNA (cfDNA) sequencing technology" Poster 2864 | 8 Sept

    Poništi
  17. 7. ruj 2019.

    Learn more about the only FDA-approved for at Roche booth 400 at Learn more at

    Poništi
  18. 6. ruj 2019.

    Ask our experts about what Roche is doing to overcome challenges in clinical NGS reporting at booth 400 Learn more at

    Poništi
  19. 6. ruj 2019.

    Don't miss the Roche Scientific Symposium on "Clinical Value of Diagnostic Agility in Managing Patients with Lung Cancer" 7 Sept, 7:30-11:30

    Poništi
  20. 6. ruj 2019.

    Visit Roche booth 400 at to learn more about our broad portfolio of oncology diagnostic solutions. Learn more at:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·